Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients

Overview

Journal Clin Transplant

Specialty General Surgery

Date 2024 Oct 10

PMID 39385672

Authors

Michael O Killian

Callie W Little

Sonnie E Mayewski

Affiliations

Soon will be listed here.

Abstract

Introduction: Limited research has explored immunosuppressant medication adherence over time in pediatric transplant patients, who often struggle with posttransplant regimen adherence, resulting in poor outcomes.

Methods: This study investigated the longitudinal growth in immunosuppressive medication levels following transplantation. Medication level variability index (MLVI) scores from tacrolimus blood levels of pediatric organ transplant recipients at a major medical center were analyzed. Linear mixed effect models (LMEM) assessed individual MLVI change trajectories and predictors of growth, exploring both linear and curvilinear growth patterns posttransplant.

Results: A sample of 181 patients with at least 4 years of MLVI data were analyzed. Growth curve modeling identified the cubic model as the best fit for the quarterly MLVI values, which significantly decreased within the first 2 years posttransplant before stabilizing. Gender significantly predicted MLVI change, with females showing greater MLVI decreases, while age at transplant did not significantly predict changes. Significant variation in MLVI among individual patients was found in all models.

Conclusions: The study demonstrated a significant decrease in MLVI values over time, indicating improved medication adherence in pediatric transplant patients, with females exhibiting more adherent growth patterns than males. Future research should aim to identify pediatric patients at high risk of nonadherence.

References

Shemesh E, Duncan S, Anand R, Shneider B, Alonso E, Mazariegos G . Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort. Liver Transpl. 2017; 24(1):80-88. PMC: 5739966. DOI: 10.1002/lt.24837. View

Wu Y, Aylward B, Steele R . Associations between internalizing symptoms and trajectories of medication adherence among pediatric renal and liver transplant recipients. J Pediatr Psychol. 2010; 35(9):1016-27. DOI: 10.1093/jpepsy/jsq014. View

Fredericks E, Magee J, Opipari-Arrigan L, Shieck V, Well A, Lopez M . Adherence and health-related quality of life in adolescent liver transplant recipients. Pediatr Transplant. 2008; 12(3):289-99. DOI: 10.1111/j.1399-3046.2008.00901.x. View

Loiselle K, Gutierrez-Colina A, Eaton C, Simons L, Devine K, Mee L . Longitudinal stability of medication adherence among adolescent solid organ transplant recipients. Pediatr Transplant. 2015; 19(4):428-35. DOI: 10.1111/petr.12480. View

de Oliveira J, Kieling C, da Silva A, Stefani J, Witkowski M, Smidt C . Variability index of tacrolimus serum levels in pediatric liver transplant recipients younger than 12 years: Non-adherence or risk of non-adherence?. Pediatr Transplant. 2017; 21(8). DOI: 10.1111/petr.13058. View

Simons L, Gilleland J, Blount R, Amaral S, Berg A, Mee L . Multidimensional Adherence Classification System: initial development with adolescent transplant recipients. Pediatr Transplant. 2008; 13(5):590-8. DOI: 10.1111/j.1399-3046.2008.01038.x. View

Dew M, DeVito Dabbs A, Myaskovsky L, Shyu S, Shellmer D, DiMartini A . Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation. 2009; 88(5):736-46. PMC: 2769559. DOI: 10.1097/TP.0b013e3181b2a0e0. View

Connelly J, Pilch N, Oliver M, Jordan C, FLEMING J, Meadows H . Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant. 2015; 19(5):555-62. DOI: 10.1111/petr.12479. View

Duncan S, Annunziato R, Dunphy C, LaPointe Rudow D, Shneider B, Shemesh E . A systematic review of immunosuppressant adherence interventions in transplant recipients: Decoding the streetlight effect. Pediatr Transplant. 2017; 22(1). PMC: 5811374. DOI: 10.1111/petr.13086. View

10.

Killian M . Psychosocial predictors of medication adherence in pediatric heart and lung organ transplantation. Pediatr Transplant. 2017; 21(4). DOI: 10.1111/petr.12899. View

11.

Killian M, Little C, Howry S, Watkivs M, Triplett K, Desai D . Demographic Factors, Medication Adherence, and Post-transplant Health Outcomes: A Longitudinal Multilevel Modeling Approach. J Clin Psychol Med Settings. 2023; 31(1):163-173. PMC: 11487835. DOI: 10.1007/s10880-023-09970-4. View

12.

Annunziato R, Fisher M, Jerson B, Bochkanova A, Shaw R . Psychosocial assessment prior to pediatric transplantation: a review and summary of key considerations. Pediatr Transplant. 2010; 14(5):565-74. DOI: 10.1111/j.1399-3046.2010.01353.x. View

13.

Vaisbourd Y, Dahhou M, Zhang X, Sapir-Pichhadze R, Cardinal H, Johnston O . Differences in medication adherence by sex and organ type among adolescent and young adult solid organ transplant recipients. Pediatr Transplant. 2022; 27(2):e14446. DOI: 10.1111/petr.14446. View

14.

Annunziato R, Jerson B, Seidel J, Glenwick D . The psychosocial challenges of solid organ transplant recipients during childhood. Pediatr Transplant. 2012; 16(7):803-11. DOI: 10.1111/j.1399-3046.2012.01749.x. View

15.

Killian M, Payrovnaziri S, Gupta D, Desai D, He Z . Machine learning-based prediction of health outcomes in pediatric organ transplantation recipients. JAMIA Open. 2021; 4(1):ooab008. PMC: 7952224. DOI: 10.1093/jamiaopen/ooab008. View

16.

Christina S, Annunziato R, Schiano T, Anand R, Vaidya S, Chuang K . Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl. 2014; 20(10):1168-77. PMC: 4177441. DOI: 10.1002/lt.23930. View

17.

Lefkowitz D, Fitzgerald C, Zelikovsky N, Barlow K, Wray J . Best practices in the pediatric pretransplant psychosocial evaluation. Pediatr Transplant. 2014; 18(4):327-35. DOI: 10.1111/petr.12260. View

18.

Shemesh E, Bucuvalas J, Anand R, Mazariegos G, Alonso E, Venick R . The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study. Am J Transplant. 2017; 17(10):2668-2678. PMC: 5607074. DOI: 10.1111/ajt.14276. View

19.

Oliva M, Singh T, Gauvreau K, VanderPluym C, Bastardi H, Almond C . Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A. J Heart Lung Transplant. 2013; 32(9):881-8. DOI: 10.1016/j.healun.2013.03.008. View

20.

Shemesh E, Fine R . Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients?. Pediatr Transplant. 2010; 14(8):940-3. PMC: 2992596. DOI: 10.1111/j.1399-3046.2010.01396.x. View